Industry: Drugs & Biotechnology
Sun Pharma makes speciality pharmaceuticals and active pharmaceutical ingredients. Their brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory.
The company has the same drive for growth that marked their early days. Sun Pharma came into existence as a startup with just 5 products in 1983. In the time since, they have crossed several milestones to emerge as a leading pharma company in India, a rank that they have now been at for more than 5 years. (IMS-ORG Retail Store Audit, March 2006)
Sun Pharma has reached leadership in each of the therapy areas that they operate in, and are rated among the leading companies by key customers. Strengthening market share and keeping this customer focus remains a high priority area for the company.
In the post 1996 years, the company has used a combination of internal growth and acquisitions to drive growth; important mergers were those of the US, Detroit based Caraco Pharm Labs and that of the plant at Halol which is now UKMHRA and USFDA approved. Under a recent corporate development, the areas related to new molecular entities and drug delivery systems are proposed to be demerged into a separate company.
